Is 80 Gy/40 Fx + ADT the new standard of care for definitive radiation of high risk prostate cancer?  

For those who want a more thorough answer, enjoy. If you want you can skip to the end for the summary: For well over a decade, we are taught that dose escalation improves biochemical control but not overall survival, while ADT improves both. Do the results of GETUG AFU-18 change this? Let's tak...

@Simul, All data points to dose (i.e., BED) mattering for higher risk CaP. That said, for amenable patients, I dose-escalate via brachy-boost following EBRT in my practice as per ASCENDE. For non-brachy candidates being treated with definitive beam, I had recently switched from standard fx 80 G...